Market Place
Sourcing Support
SOTIO Showcases SOT201, VICTORIA-01 & BOXR CAR-T Data at SITC 2024
07 Nov 2024 //
BUSINESSWIRE
Sotio Announces Upcoming Presentations At SITC 2024
22 Oct 2024 //
BUSINESSWIRE
SOTIO And Biocytogen Partner On Multi-Target Antibodies For ADC Pipeline
16 Jul 2024 //
BUSINESSWIRE
Sotio taps Biocytogen to create bispecific ADCs in $326M deal
16 Jul 2024 //
FIERCE BIOTECH
SOTIO: First Patient Dosed In SOT201 Phase 1 Solid Tumor Study
28 May 2024 //
BUSINESSWIRE
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual Meeting
23 May 2024 //
BUSINESSWIRE
SOTIO Presents Data on SOT201 Immunocytokine at SITC Annual Meeting
31 Oct 2023 //
BUSINESSWIRE
After halting lead asset, Sotio signs $740M deal with Synaffix
17 Oct 2023 //
FIERCE BIOTECH
SOTIO Enters Licensing Agreement With Synaffix to Expand ADC Pipeline
16 Oct 2023 //
PR NEWSWIRE
SOTIO Expands ADC Platform with License to Synaffix’s ADC Technology
16 Oct 2023 //
BUSINESSWIRE
SOTIO Provides Update on Interim Data from Clinical Trials of Nanrilkefusp Alfa
13 Oct 2023 //
BUSINESSWIRE
Sotio terminates three trials studying its IL-15 superagonist
13 Oct 2023 //
ENDPTS
SOTIO Announces First Patients Dosed in Two Combination Arms of CLAUDIO-01 Study
11 Oct 2023 //
BUSINESSWIRE
SOTIO Doses First Patient in AURELIO-05 PII Trial of Nanrilkefusp with Cetuximab
19 Jan 2023 //
GLOBENEWSWIRE
SOTIO Presents Preclinical Data from BOXR CAR-T & Trial of Ph 2 AURELIO-04
10 Nov 2022 //
GLOBENEWSWIRE
SOTIO to Present the AURELIO-04 Phase 2 Study Design
18 Oct 2022 //
GLOBENEWSWIRE
SOTIO Doses First Patient in AURELIO-04 PII Trial of SOT101 + KEYTRUDA
26 Jul 2022 //
GLOBENEWSWIRE
Data from SOTIO`s Phase 1/1b AURELIO-03 Trial of SOT101 in Solid Tumors
26 May 2022 //
GLOBENEWSWIRE
SOTIO Initiates CLAUDIO-01 Trial with Antibody-Drug Conjugate SOT102
26 Apr 2022 //
GLOBENEWSWIRE
SOTIO says Oral and Multiple Poster Presentations on Key Programs at AACR
16 Mar 2022 //
GLOBENEWSWIRE
Fresh from $316M raise, Sotio inks Merck deal for Keytruda combo trial
09 Dec 2021 //
FIERCEBIOTECH
A quiet Czech biotech bags $315M to drive its cancer pipeline
02 Dec 2021 //
ENDPTS
SOTIO Strengthens its Strategic Advisory Board with Esteemed Oncology Experts
18 Nov 2021 //
GLOBENEWSWIRE
SOTIO expands its ADC pipeline via agreement with LegoChem
17 Nov 2021 //
THEPHARMALETTER
SOTIO, LegoChem Biosciences Enter ADC License Agreement
16 Nov 2021 //
CONTRACTPHARMA
SOTIO Expands its Antibody-Drug Conjugate Pipeline with Exclusive Collaboration
16 Nov 2021 //
GLOBENEWSWIRE
SOTIO to Present New Data from Phase 1 Study of SOT101
03 Nov 2021 //
GLOBENEWSWIRE
SOTIO to Present Biomarker Data from its SOV01 – DCVAC/OvCa Phase 2 Study
11 May 2021 //
GLOBENEWSWIRE
SOTIO Demonstrates Strong Potential of SOT102 (ADC Targeting Claudin 18.2)
13 Apr 2021 //
GLOBNEWSWIRE
SOTIO to Present Preclinical Results Describing SOT102
06 Apr 2021 //
GLOBENEWSWIRE
SOTIO Presents Interim Data from its Ph1/1b Study of SO-C101
11 Nov 2020 //
GLOBENEWSWIRE
SOTIO to Present New Data on the IL-15 superagonist SO-C101
04 Nov 2020 //
GLOBENEWSWIRE
Sotio Acquires Rights to BOXR Cell Therapy Platform
31 Aug 2020 //
CONTRACTPHARMA
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics
31 Aug 2020 //
GLOBENEWSWIRE
